Recently, CD40/CD40L pathway activation and a subsequent proinflamatory milieu were reported in diseases such as obesity [24, 25], diabetes mellitus [26] and hypertension [27]. This evidence concerns the gene CD40 and obesity due to melanocortin 4 receptor deficiency.